Wednesday, April 22, 2020

5:00 PM-6:15 PM


Live Webinar


Barry J. Make, MD
Professor of Medicine
Division of Pulmonary, Critical Care, and Sleep Medicine
University of Colorado School of Medicine
Co-Director, COPD Program
Director, Pulmonary Rehabilitation and Respiratory Care
Department of Medicine
National Jewish Health
Denver, Colorado

Richard H. Stanford, PharmD, MS
Vice President
Adjunct Assistant Professor
University of North Carolina Eshelman School of Pharmacy
Chapel Hill, North Carolina

Barbara P. Yawn, MD, MSc, FAAFP
Adjunct Professor
Department of Family and Community Health
University of Minnesota
Rochester, Minnesota

This activity is jointly provided by Global Education Group and Integritas Communications.

This activity is supported by an independent educational grant from AstraZeneca.

Held in conjunction with AMCP eLearning Days.

This event will be hosted via Adobe Connect
please click here to


There is no registration fee for attending this virtual satellite symposium; however, participation is limited. 

Target Audience

The educational design of this activity addresses the needs of managed care pharmacists, medical directors, and other health care professionals who help guide the treatment of patients with chronic obstructive pulmonary disease (COPD).

Program Description

The biopsychosocial and economic impact of COPD is substantial. Preventing exacerbations by optimizing the delivery of COPD care across the health care continuum is imperative to achieving the ultimate goal of improved patient outcomes. This engaging live webinar will assemble a multidisciplinary faculty panel consisting of a pulmonologist, a primary care physician, and a managed care pharmacist to provide expert insights and discuss best practices in the management of COPD—including exacerbation risk prevention and available and emerging therapeutic options—and how these factors may be used to shape managed care pharmacy decisions and future managed care paradigms. Pertinent patient case studies will also be utilized to provide examples of how recommended approaches to evidence and value-based care can be collaborative applied to health care systems.

Learning Objectives

Upon completion of this activity, the participant should be better able to:

  • Characterize the clinical, economic, and health care utilization burdens of COPD exacerbations
  • Discuss the latest evidence-based guidelines on COPD exacerbation prevention
  • Describe the clinical profiles and potential cost offsets associated with newer maintenance treatment options for COPD
  • Update benefit design strategies with new data and treatment modalities to optimize health care access and outcomes for patients with COPD


  • Participant Log-in and COPD Factoids
  • Welcome and Faculty Introductions
  • The Impact of COPD Exacerbations: A Patient Perspective
  • The Impact of COPD Exacerbations: Resource Utilization and Cost
  • Recommendations for COPD Exacerbation Prevention
  • Managed Care Strategies to Reduce COPD Exacerbation Risks
  • Question and Answer Session

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas.  Global is accredited by the ACCME to provide continuing medical education for physicians.

*This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement

Global is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Global designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Credit (Universal Activity Number – 0530-9999-20-051-L01-P).

This is a knowledge-based activity.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete an online evaluation form. For ACPE learners, please check the CPE monitor for your CE credit within 60 days of the activity.

Disclosure of Conflicts of Interest

Global requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Fee Information& Refund/Cancellation Policy

There is no fee for this educational activity.

Register Today!

Related events
Regional Meeting Series
1.00 CME/CE


Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention

Time: 12:00 PM-1:00 PM CT
Venue: In-Person Training - Aletheia House Staff
Location: Bessemer, AL
Faculty: Gregory Felzien, MD, AAHIVS
available resources
meeting slides
interactive presentation
linked resources
Suggested Reading
Point-of-Care 101™

COPD in Managed Care

The Clinical and Utilization Benefits of Exacerbation Prevention